![Lon Cardon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lon Cardon
Director/Board Member at
MIRUM PHARMACEUTICALS, INC.
Net worth: 982 520 $ as of 2026-05-30
Profile
Presently, Lon Cardon holds the position of Chief Scientific Strategy Officer & Senior VP at BioMarin Pharmaceutical, Inc. Dr. Cardon is also on the board of Reneo Pharmaceuticals, Inc. and Senior Vice President-Target Sciences at GlaxoSmithKline Plc, Professor at the University of Washington, Professor at the University of Oxford and Professor at Fred Hutchinson Cancer Research Center. He received a doctorate from The University of Colorado.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-14 | 9,680 ( 0.02% ) | 982 520 $ | 2026-05-30 |
Lon Cardon active positions
| Companies | Position | Start |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Director/Board Member | 2022-12-18 |
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Chief Executive Officer | 2021-11-28 |
Former positions of Lon Cardon
| Companies | Position | End |
|---|---|---|
| ONKURE THERAPEUTICS, INC. | Director/Board Member | 2022-05-31 |
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 2021-10-31 |
| GSK PLC | Corporate Officer/Principal | 2017-08-31 |
Open Targets
 Open Targets Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Founder | - |
Altius Institute For Biomedical Sciences
 Altius Institute For Biomedical Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit research organization for the discovery of biomedicine | Founder | - |
Training of Lon Cardon
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Puget Sound
 University of Puget Sound Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Health Technology |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
National Human Genome Research Institute
 National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Government |
Reneo Pharmaceuticals, Inc.
 Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Open Targets
Open Targets Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Altius Institute For Biomedical Sciences
Altius Institute For Biomedical Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit research organization for the discovery of biomedicine | Commercial Services |
- Stock Market
- Insiders
- Lon Cardon
